Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can bedside ultrasound guide fluid treatment for cirrhosis patients?

NCT ID NCT07810855

Knowledge-focused Sponsor: Royal Free Hospital NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers are studying whether repeated bedside ultrasound scans of the neck, chest, and abdomen can be done reliably in hospitalized patients with cirrhosis and ascites. The study also asks how long the scans take, how often all measurements can be captured, and how patients feel about the test. Participants may have scans up to five times a day during their hospital stay, plus an extra blood draw and a short questionnaire. The goal is to see if this approach could help doctors manage fluid balance more precisely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
point-of-care ultrasound measurements of neck, chest, and abdominal blood vessels
What this could lead to
If the scans prove practical and acceptable, doctors could use them to tailor fluid treatment for cirrhosis patients with ascites, potentially avoiding both dehydration and fluid overload.
What could go wrong
This is a small observational study on hospital wards, so it may not show that ultrasound-guided fluid management improves outcomes. The scans could be hard to perform consistently, and patient feedback might reveal discomfort or inconvenience.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Participants under the care of the hepatology team at the Royal Free Hospital will be recruited from the emergency department, wards or ambulatory care.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must be capable of giving informed consent * Hospitalized patients with liver cirrhosis (of any cause) and clinically significant ascites * \> 18 years of age Exclusion Criteria: * patients receiving end of life care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ascites hepatic are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ascites hepatic Cirrhosis Fluid balance

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.